Clinical Trials in Tennessee

Showing 6941-6960 of 15,329 trials

Cisplatin, Irinotecan and Bevacizumab (PCA) Versus Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer

NCT00911820

There is no clear standard of care for metastatic stomach or esophageal cancer in the United States. The purpose of this research study is to determine the differences between two regimens of chemotherapy; Arm A: PCA (Cisplatin, Irinotecan and Bevacizumab) and Arm B: TPCA (Docetaxel, Cisplatin, Irinotecan and Bevacizumab). Docetaxel, Cisplatin, and Irinotecan are traditional chemotherapy drugs. Bevacizumab is an antibody (a protein that attacks a foreign substance in the body). Bevacizumab is believed to stop the formation of new blood vessels that carry nutrients to tumors. Both of the chemotherapy regimens (PCA and TPCA) have been studied in patients with esophageal and gastric cancer, and we are trying to determine if one regimen will keep your cancer from growing and improve how long you can live.

Esophageal CancerGastric CancerStomach Cancer

Dana-Farber Cancer Institute88 participantsStarted Jul 2009

Boston, Massachusetts, United States • Boston, Massachusetts, United States • Nashville, Tennessee, United States +1 more locations

TERMINATEDPhase 2/329 miles

TD-1473 Long-Term Safety (LTS) Ulcerative Colitis (UC) Study

NCT03920254

A 3-Year Multi-Center, Long-Term Safety (LTS) Study to Evaluate the Safety and Tolerability of TD-1473 in Subjects with Ulcerative Colitis who have participated in the Maintenance Study of Protocol 0157

Ulcerative Colitis (UC)

Theravance Biopharma46 participantsStarted Jul 2020

Chula Vista, California, United States • Lancaster, California, United States • Orange, California, United States +181 more locations

Cisplatin, Irinotecan and Bevacizumab (PCA) Versus Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer

TD-1473 Long-Term Safety (LTS) Ulcerative Colitis (UC) Study

Find Trials by Condition in Tennessee

Telehealth Mindfulness-Based Music and Songwriting for Parents of Children With Intellectual/Developmental Disabilities

Safety and Efficacy of Tenalisib (RP6530) in Combination With Romidepsin in Patients With Relapsed/Refractory T-cell Lymphoma

A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus

LDL-C Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2

Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy

Safety and Pharmacokinetics of Dapivirine Vaginal Ring in Post-menopausal Women

An Investigational Immuno-therapy Trial of Pomalidomide and Low-dose Dexamethasone With or Without Elotuzumab to Treat Refractory and Relapsed and Refractory Multiple Myeloma (ELOQUENT-3)

A Study to Assess the Safety and Efficacy of Etrasimod in Subjects With Moderate-to-Severe Atopic Dermatitis

Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects

Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)

Evaluating the Efficacy of Dual Layer Amniotic Membrane (Artacent®)

Randomized, Double-Blind, Placebo-Controlled Trial, Followed by Single-Arm Treatment of PRO 140

A Safety, Pharmacokinetic & Dose-Escalation Study of KD019 in Subjects With Autosomal Dominant Polycystic Kidney Disease

NovoTTF Therapy in Treating Patients With Recurrent Glioblastoma Multiforme

Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL

A Study to Assess Long-term Safety, Tolerability and Efficacy of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Sodium Pyruvate Nasal Spray Treatment of COVID-19 Infection

Diagnostic Accuracy Of Forced Oscillation Technique To Detect Lung Function Anomalies